US Executive Compensation Proxy SEC Filings — June 30, 2026

Executive Compensation Insights

By Gunpowder Editorial ·

9 high priority 9 total filings analysed

Executive Summary

The 9 filings in this stream reveal a mix of routine governance proposals and a few significant corporate actions. Notable trends include two Nuveen municipal bond funds proposing mergers to streamline operations, which carry tax implications for shareholders. Silo Pharma seeks a massive increase in authorized shares (from 6.7M to 250M), a potential dilution risk.

Insider trading activity is absent across filings, limiting conviction signals. Compensation data shows mixed trends: Silo Pharma's PEO pay declined 21% YoY while average non-PEO NEO pay rose 8%. Most filings are low-materiality proxy statements with standard director elections and auditor ratifications. The upcoming annual meetings in July-August 2026 create a catalyst calendar for governance votes.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: DEF 14A

Tracking the trend? Catch up on the prior US Executive Compensation Proxy SEC Filings digest from June 22, 2026.

Investment Signals (10)

  • PEO compensation actually paid declined 20.9% YoY from $630,051 to $498,536, while average non-PEO NEO pay increased 8.0% from $88,600 to $95,691, suggesting tighter alignment with shareholder interests

  • Proposal to increase authorized shares from 6,666,667 to 250,000,000 (3,650% increase) could enable future acquisitions or capital raises but poses significant dilution risk

  • Merger into Nuveen Municipal Credit Income Fund expected to increase net earnings and liquidity, but loss of state tax exemption may reduce after-tax returns for Virginia investors

  • Similar merger benefits of higher earnings and lower expenses, but increased exposure to lower-rated securities raises credit risk

  • Owlet (NEUTRAL)

    Virtual annual meeting on Aug 12, 2026 with proposals including executive compensation approval and share reserve increase for incentive plan, indicating potential equity compensation expansion

  • Special meeting on July 22, 2026 to vote on two new equity incentive plans (2025 and 2026), suggesting aggressive equity compensation strategy post-annual report filing

  • Annual meeting on Aug 10, 2026 with 18.6M shares outstanding, no major proposals beyond director elections and auditor ratification, indicating stable governance

  • Class II director elections split between common/preferred stockholders, with preferred stockholders solely electing one director, reflecting dual-class structure

  • Only proposals are trustee re-election and auditor ratification, no financial performance data disclosed, suggesting minimal shareholder engagement

  • Cycurion (BEARISH)

    CEO/Chairman duality with L. Kevin Kelly holding both roles, and compensation committee did not engage a consultant in 2025, raising governance concerns

Risk Flags (9)

  • Authorized share increase from 6.7M to 250M (3,650%) could massively dilute existing shareholders if fully utilized, with no specific use disclosed

  • Merger eliminates Virginia state tax exemption for common shareholders, potentially reducing after-tax yield for in-state investors

  • Similar loss of Minnesota state tax exemption, impacting tax-sensitive investors

  • Nuveen Funds/Credit Risk [MEDIUM RISK]

    Combined fund will invest more in lower-rated securities, increasing default risk and volatility

  • No formal policy separating CEO and Chairman roles, and compensation committee lacked independent consultant, potentially leading to pay-for-performance misalignment

  • Approval of two new equity incentive plans could lead to significant share issuance, diluting existing holders

  • Non-binding advisory vote on executive compensation may indicate shareholder dissatisfaction if pay is not aligned with performance

  • Proxy statement contains no financial results or performance data, limiting shareholder ability to assess fund performance

  • Preferred stockholders have separate voting rights for one director, which could create conflicts with common shareholders

Opportunities (7)

Sector Themes (5)

  • Municipal Bond Fund Consolidation

    Two Nuveen funds propose mergers to streamline operations, reflecting industry trend of consolidation to achieve scale and reduce expenses, but at cost of state tax benefits

  • Micro-Cap Dilution Risk

    Silo Pharma and CEA Industries both seek significant equity issuance (authorized shares and new plans), common in micro-caps for funding but risky for shareholders

  • Governance Structure Variations

    Cycurion's CEO/Chairman duality contrasts with more independent structures at other firms, highlighting governance diversity among small caps

  • Low Insider Activity

    No insider trading disclosed across all 9 filings, suggesting management may not be signaling conviction through personal transactions

  • Virtual Meeting Adoption

    Multiple companies (Owlet, CEA Industries) hold virtual-only meetings, reducing shareholder engagement costs but potentially limiting dialogue

Watch List (7)

  • Annual meeting on Aug 14, 2026 to vote on massive share increase; monitor for management's use of proceeds and any insider buying/selling post-meeting

  • Nuveen Virginia & Minnesota
    👁

    Special meetings for merger approval; watch for shareholder vote results and any dissenting opinions from large holders

  • Special meeting on July 22, 2026; approval of equity plans could signal future capital raises or acquisitions

  • 👁

    Annual meeting on Aug 12, 2026; advisory vote on executive compensation may indicate pay satisfaction levels

  • Annual meeting on Aug 10, 2026; monitor for any unexpected proposals or activist activity

  • Annual meeting on Aug 13, 2026; preferred stock voting dynamics could affect governance

  • Annual meeting on Aug 4, 2026; lack of financial disclosure warrants monitoring for future performance reports

Filing Analyses (9)
Silo Pharma, Inc. DEF 14A neutral materiality 7/10

30-06-2026

Silo Pharma, Inc. filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting scheduled for August 14, 2026. Key proposals include electing four directors, ratifying Salberg & Company as auditor, and a significant increase in authorized common shares from 6,666,667 to 250,000,000. The filing also discloses executive compensation, with PEO compensation actually paid declining from $630,051 in 2024 to $498,536 in 2025, while average non-PEO NEO compensation actually paid increased from $88,600 to $95,691 over the same period.

  • · Annual Meeting to be held August 14, 2026 at 11:00 a.m. Eastern at 677 N Washington Boulevard, Sarasota, FL 34236.
  • · Record date for voting is June 18, 2026; 1,128,610 shares outstanding.
  • · Proposal to increase authorized common shares from 6,666,667 to 250,000,000.
  • · Proposal to ratify Salberg & Company as independent auditor for FY 2026.
  • · Quorum requires one-third of outstanding shares (376,205 shares).
  • · PEO CAP declined ~20.9% from $630,051 in 2024 to $498,536 in 2025.
  • · Average non-PEO NEO CAP increased ~8.0% from $88,600 in 2024 to $95,691 in 2025.
Owlet, Inc. DEF 14A neutral materiality 5/10

30-06-2026

Owlet, Inc. filed a definitive proxy statement (DEF 14A) on June 30, 2026, for its 2026 Annual Meeting of Stockholders to be held virtually on August 12, 2026. The meeting includes proposals to elect Marc F. Stoll and Kurt Workman as Class II directors, approve executive compensation on a non-binding advisory basis, ratify PricewaterhouseCoopers LLP as independent auditor for 2026, and approve an amendment to the 2021 Incentive Award Plan to increase the share reserve. The record date for voting is June 15, 2026.

  • · Annual Meeting will be held virtually on August 12, 2026 at 1:00 p.m. Eastern Time.
  • · Record date for voting is June 15, 2026.
  • · Stockholders can access the meeting at www.virtualshareholdermeeting.com/OWLT2026 using a 16-digit control number.
  • · Proposals include: electing two Class II directors, advisory vote on executive compensation, frequency of future advisory votes, ratification of auditor, and amendment to the 2021 Incentive Award Plan.
  • · Proxy materials are being distributed via the Notice and Access method, with electronic delivery encouraged.
  • · The company's principal executive offices are located at 2940 W Maple Loop Drive, Suite 203, Lehi, Utah 84048.
NUVEEN VIRGINIA QUALITY MUNICIPAL INCOME FUND DEF 14A mixed materiality 8/10

30-06-2026

Nuveen Virginia Quality Municipal Income Fund (NPV) is soliciting shareholder approval for a merger into Nuveen Municipal Credit Income Fund (the Acquiring Fund) as part of an initiative to streamline Nuveen's municipal closed-end fund line-up. The merger is expected to benefit common shareholders through higher net earnings, greater liquidity, and lower operating expenses, but will result in the loss of the Virginia state tax exemption and increased exposure to lower-rated securities. Preferred shareholders (VRDP Shares) will receive substantially similar shares in the Acquiring Fund, but without the state-specific tax gross-up provision; however, this change will not affect current preferred holders, who are all institutional and ineligible for the gross-up.

  • · The merger is subject to approval by both common and preferred shareholders of NPV at a special meeting.
  • · The Acquiring Fund has a national mandate with greater flexibility to invest in lower-rated securities, which carries higher risk.
  • · For the last 10+ years, neither the Target Funds nor the Acquiring Fund have allocated capital gains/ordinary income that would trigger a gross-up payment to preferred shareholders.
  • · The combined fund will have multiple series and types of preferred shares outstanding, potentially diluting the percentage holdings of existing preferred shareholders.
  • · The outstanding VRDP Shares of Virginia Municipal are owned by a single institutional holder.
Nuveen Minnesota Quality Municipal Income Fund DEF 14A mixed materiality 7/10

30-06-2026

Nuveen Minnesota Quality Municipal Income Fund (NMS) and Nuveen Virginia Quality Municipal Income Fund (NPV) are soliciting shareholder approval to merge into Nuveen Municipal Credit Income Fund (the Acquiring Fund). The Boards unanimously recommend the mergers, citing potential benefits such as higher common share net earnings, greater secondary market liquidity, increased portfolio flexibility, and lower total operating expenses. However, shareholders will lose the benefit of state tax exemptions, and the combined fund will invest more in lower-rated securities, increasing risk. Preferred shareholders will receive substantially similar shares in the Acquiring Fund, but without the state-specific tax gross-up provision, though this is not expected to impact current institutional holders.

  • · The outstanding AMTP Shares of Minnesota Municipal and VRDP Shares of Virginia Municipal are each owned by a single institutional holder.
  • · For the last 10+ years, neither the Target Funds nor the Acquiring Fund have allocated any capital gains and/or ordinary income to a given month’s distribution that would have required a gross-up payment (federal or state).
  • · The Acquiring Fund expects that practice of not requiring gross-up payments to continue going forward.
  • · If a Merger were to result in tax disadvantages to a Target Fund preferred shareholder, the shareholder may seek to negotiate adjustments to the terms of the preferred shares of the Acquiring Fund it owns following the Merger.
Cycurion, Inc. DEF 14A neutral materiality 3/10

30-06-2026

Cycurion, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting, detailing corporate governance practices, director independence, and committee structures. The Board consists of five directors, with three independent members (Peter R. Ginsberg, Reginald S. Bailey, Sr., Kevin E. O'Brien) serving on all three standing committees. The filing also outlines voting procedures, risk oversight responsibilities, and the absence of a formal policy separating CEO and Chairman roles, with L. Kevin Kelly holding both positions.

  • · The Compensation Committee did not engage a compensation consultant for the 2025 fiscal year.
  • · The Audit Committee is comprised of three independent directors: Peter R. Ginsberg, Reginald S. Bailey, Sr., and Kevin E. O'Brien.
  • · The Board has determined that having L. Kevin Kelly serve as both CEO and Chairman is in the best interest of stockholders at this time.
  • · The Company will bear the cost of proxy solicitation and will reimburse banks, brokers, and other nominees for reasonable expenses.
  • · Voting results will be published in a Form 8-K within four business days of the Annual Meeting.
Bluerock Private Real Estate Fund DEF 14A neutral materiality 3/10

30-06-2026

Bluerock Private Real Estate Fund (BPRE) filed a definitive proxy statement (DEF 14A) for its 2026 annual meeting of shareholders to be held virtually on August 4, 2026. The Board unanimously recommends voting FOR the re-election of Class I Trustees I. Bobby Majumder and Romano Tio (Proposal 1) and FOR the ratification of Cohen & Company, Ltd. as independent auditor for fiscal year ending September 30, 2026 (Proposal 2). The filing contains no financial results or performance data, focusing solely on governance and auditor ratification.

  • · Record date for voting is June 15, 2026.
  • · Deadline to submit proxy vote is 11:59 p.m. ET on August 3, 2026.
  • · Deadline to request virtual meeting credentials is 12:00 p.m. ET on August 3, 2026.
  • · Proposal 1 requires a plurality of votes cast; Proposal 2 requires majority of shares present at the meeting.
  • · Both proposals are considered routine matters by NYSE, allowing brokers discretionary voting.
  • · The Fund is a closed-end fund listed on NYSE and organized as a Delaware statutory trust.
  • · Proxy materials are available at https://proxyvotinginfo.com/p/bpre2026.
Stabilis Solutions, Inc. DEF 14A neutral materiality 3/10

30-06-2026

Stabilis Solutions, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting to be held on August 10, 2026. The meeting will include the election of six director nominees and ratification of the independent auditor. The record date is June 8, 2026, with 18,596,301 shares outstanding.

  • · Annual Meeting date: August 10, 2026 at 9:00 a.m. Central Daylight Time
  • · Record date: June 8, 2026
  • · Proposals: Election of six directors and ratification of independent registered public accounting firm for 2026
  • · Proxy materials available on or about June 30, 2026
  • · Stockholders can vote via internet, telephone, mail, or in person
  • · Broker non-votes and abstentions count for quorum purposes
OFS Credit Company, Inc. DEF 14A neutral materiality 3/10

30-06-2026

OFS Credit Company, Inc. filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Stockholders to be held on August 13, 2026. The meeting will include the election of two Class II directors: Kate M. Fitta (to be elected by common and preferred stockholders voting together) and Romita Shetty (to be elected solely by preferred stockholders), as well as the ratification of KPMG LLP as the independent registered public accounting firm for fiscal year ending October 31, 2026. As of the record date of June 18, 2026, the company had 29,372,401 shares of common stock and 3,596,000 shares of preferred stock outstanding.

  • · The Annual Meeting will be held on Thursday, August 13, 2026 at 10:00 a.m. local time at 222 West Adams Street, Suite 1850, Chicago, Illinois 60606.
  • · The record date for determining stockholders entitled to vote is Thursday, June 18, 2026.
  • · Each share of Common Stock and Preferred Stock entitles the holder to one vote on all matters submitted to stockholders.
  • · For the election of Kate M. Fitta, a plurality of votes of Common and Preferred Stock voting together is required; for Romita Shetty, a plurality of votes of Preferred Stock voting as a single class is required.
  • · Ratification of KPMG LLP requires the affirmative vote of a majority in voting power of shares present and voting on the proposal.
  • · Brokers have discretionary authority to vote on the ratification of KPMG LLP but not on the election of directors.
CEA Industries Inc. DEF 14A neutral materiality 5/10

30-06-2026

CEA Industries Inc. filed a definitive proxy statement (DEF 14A) on June 30, 2026, for a Special Meeting in Lieu of Annual Meetings to be held virtually on July 22, 2026. Stockholders will vote on six proposals, including the election of six director nominees, ratification of Sadler, Gibb & Associates as auditor for FY ending April 30, 2027, an advisory vote on executive compensation, and approval of two new equity incentive plans (2025 and 2026). The record date is June 22, 2026, with 41,173,850 shares of common stock outstanding and entitled to vote.

  • · The Special Meeting will be held virtually on July 22, 2026 at 9:00 a.m. Eastern Time via www.virtualshareholdermeeting.com/BNC2026SM.
  • · Proxy materials first mailed to stockholders on or about June 30, 2026.
  • · The Company's Annual Report on Form 10-K for FY ended April 30, 2026 was filed with the SEC on June 23, 2026.
  • · Stockholders may vote by telephone (1-800-690-6903) or internet (www.proxyvote.com) until 11:59 p.m. ET on July 21, 2026.
  • · Abstentions and broker non-votes count as present for quorum purposes.
  • · If a quorum is not present, stockholders may adjourn the meeting until a quorum is present.

Get daily alerts with 10 investment signals, 9 risk alerts, 7 opportunities and full AI analysis of all 9 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Executive Compensation Proxy SEC Filings

🇺🇸 More from United States

View all →